*Patient is not eligible if he/she participates in or seeks reimbursement or submits a claim for reimbursement to any federal or state healthcare program with prescription drug coverage. Maximum benefits and other restrictions apply. Visit https://www.ucerisfoam.com/savings for full eligibility criteria and terms and conditions. Salix Pharmaceuticals reserves the right to modify or cancel these offerings at any time.
UCERIS® (budesonide) rectal foam is a prescription corticosteroid medicine used to help get active, mild to moderate ulcerative colitis that extends from the rectum to the sigmoid colon under control (induce remission). It is not known if UCERIS rectal foam is safe and effective in children.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
For product information, adverse event reports, and product complaint reports, please contact: Salix Product Information Call Center
Please click here for full Prescribing Information for UCERIS rectal foam.
The healthcare information contained herein is not intended to replace discussion with your healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.
The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.